Psychology Department, University of Florida, Gainesville, FL, USA.
Stress. 2020 Nov;23(6):638-650. doi: 10.1080/10253890.2020.1803824. Epub 2020 Aug 24.
Post-traumatic stress disorder (PTSD) is often comorbid with cocaine use disorder (CUD), but little is known about hypothalamic-pituitary-adrenal (HPA) axis function in PTSD + CUD. Here we review the clinical and pre-clinical literature of PTSD and CUD with the goal of generating hypotheses about HPA axis activity in comorbid PTSD + CUD. Low glucocorticoid (CORT) levels immediately after trauma exposure are associated with PTSD. CORT administered within 12 h of trauma exposure reduces later PTSD symptoms. Weeks-years after trauma, meta-analyses find lower CORT levels in patients with PTSD relative to never-traumatized controls; the same is found in a pre-clinical model of PTSD. In rodents, reduced basal CORT levels are consistently found after chronic cocaine self-administration. Conversely, increased CORT levels are found in CUD patients during the first 2 weeks of cocaine abstinence. There is evidence for CORT hyper-suppression after dexamethasone, high glucocorticoid receptor (GR) number pre-trauma, and increased GR translocation to the nucleus in PTSD. Hyper-suppression of HPA axis activity after dexamethasone suggests that PTSD individuals may have increased anterior pituitary GR. Given evidence for decreased anterior pituitary GR in rats that self-administer cocaine, PTSD + CUD individuals may have normal GR density and low basal CORT levels during late abstinence. Future studies should aim to reconcile the differences in pre-clinical and clinical basal CORT levels during cocaine and assess HPA axis function in both rodent models of CUD that consider stress-susceptibility and in PTSD + CUD individuals. Although additional studies are necessary, individuals with PTSD + CUD may benefit from behavioral and psychopharmacological treatments to normalize HPA axis activity. LAY SUMMARY Post-traumatic stress disorder (PTSD) is often comorbid with cocaine use disorder (CUD), but little is known about the hypothalamic-pituitary-adrenal (HPA) axis function in PTSD + CUD. The current review provides a synthesis of available clinical and pre-clinical data on PTSD and CUD with the goal of generating hypotheses about HPA axis activity in comorbid PTSD + CUD. While this review finds ample evidence supporting aberrant HPA axis activity in both PTSD and CUD, it suggests that more research is needed to understand the unique changes HPA axis activity in PTSD + CUD, as well as the bidirectional relationship between stress-susceptibility and motivation to seek cocaine.
创伤后应激障碍(PTSD)常与可卡因使用障碍(CUD)共病,但人们对 PTSD+CUD 患者的下丘脑-垂体-肾上腺(HPA)轴功能知之甚少。在这里,我们综述了 PTSD 和 CUD 的临床和临床前文献,旨在提出关于共病 PTSD+CUD 患者 HPA 轴活性的假说。创伤后即刻的低皮质醇(CORT)水平与 PTSD 有关。创伤后 12 小时内给予 CORT 可减轻后期 PTSD 症状。创伤后数周-数年,荟萃分析发现 PTSD 患者的 CORT 水平低于从未受过创伤的对照组;在 PTSD 的临床前模型中也发现了同样的情况。在啮齿动物中,慢性可卡因自我给药后,基础 CORT 水平持续降低。相反,在可卡因戒断的前 2 周,CUD 患者的 CORT 水平升高。有证据表明,地塞米松后 HPA 轴活性过度抑制,创伤前糖皮质激素受体(GR)数量增加,以及 PTSD 中 GR 向核内易位增加。地塞米松后 HPA 轴活性过度抑制表明,PTSD 个体可能在前垂体 GR 增加。鉴于可卡因自我给药的大鼠前垂体 GR 减少的证据,PTSD+CUD 个体在晚期戒断期间可能具有正常的 GR 密度和低基础 CORT 水平。未来的研究应旨在调和可卡因和评估应激易感性和 PTSD+CUD 个体的两种可卡因使用障碍啮齿动物模型中 CORT 水平的临床前和临床差异,并研究 HPA 轴功能。尽管还需要更多的研究,但 PTSD+CUD 个体可能受益于行为和精神药理学治疗以使 HPA 轴活动正常化。
非专业人士,仅供参考。